Viewing Study NCT02846792


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-01-03 @ 11:05 PM
Study NCT ID: NCT02846792
Status: TERMINATED
Last Update Posted: 2019-03-04
First Post: 2016-07-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
Sponsor: University of Washington
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 9602
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View